Niphadkar 2005b.
Methods | See above. | |
Participants | See above. | |
Interventions | 1. Ciclesonide 200 mcg OD (pm)
2. Budesonide 200 mcg BID See above |
|
Outcomes | FEV1; FVC; am PEF; pm PEF; symptoms; rescue medication use; withdrawals; adverse events | |
Notes | Created as secondary reference to Niphadkar 2005 (am) due to additional treatment arm in this trial (pm administration of ciclesonide) | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |